IDO1 and cancer: In addition, enrichment analysis identified links to metabolic pathways such as glycolysis and fatty acid metabolism, as well as pathways involved in cancer immune evasion (e.g., IDO1 activity and effector T cell suppression) (Fig. S1a-d).